10-Q Filing

BNB PLUS CORP. CIK: 744452 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001410578-22-000113`
Period End Date	20211231
Filing Date	20220210
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	apdn-20211231x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 38 Cash Flow Statement 54 Stockholders Equity 19

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$29.82K	USD	Point-in-time
Allowance on accounts receivable (in dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$39.82K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.75M	USD	Point-in-time
Accounts receivable, net of allowance of $39,821 and $29,821 at December 31, 2021 and September 30, 2021, respectively	`AccountsReceivableNetCurrent`	$3.86M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $39,821 and $29,821 at December 31, 2021 and September 30, 2021, respectively	`AccountsReceivableNetCurrent`	$2.80M	USD	Point-in-time
Inventories	`InventoryNet`	$1.30M	USD	Point-in-time
Inventories	`InventoryNet`	$1.37M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$568.88K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$593.15K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.30M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.02M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.49M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.81M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	7.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.04K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$95.04K	USD	Point-in-time
Total Assets	`Assets`	$14.42M	USD	Point-in-time
Total Assets	`Assets`	$11.40M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.99M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.52M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$457.54K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$281.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.98M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.27M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.01M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.30M	USD	Point-in-time
Commitments and contingencies (Note F)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note F)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2021 and September 30, 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2021 and September 30, 2021, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2021 and September 30, 2021, 7,486,120 shares issued and outstanding as of December 31, 2021 and September 30, 2021	`CommonStockValue`	$7.49K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2021 and September 30, 2021, 7,486,120 shares issued and outstanding as of December 31, 2021 and September 30, 2021	`CommonStockValue`	$7.49K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$297.23M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$295.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-284.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-288.84M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$8.39M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity:	`StockholdersEquity`	$11.11M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$133.00	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-722.00	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$14.42M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$11.40M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.17M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.62M	USD	1 Quarter
Total cost of product and clinical laboratory service revenues	`CostOfRevenue`	$515.78K	USD	1 Quarter
Total cost of product and clinical laboratory service revenues	`CostOfRevenue`	$3.06M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.10M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.11M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.66M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.31M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.08M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$763.81K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.07M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.74M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-4.63M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.97M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-5.44K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$273.00	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-88.05K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-53.86K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.72M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.81M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-4.72M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-4.81M	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.49K	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$855.00	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.72M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.81M	USD	1 Quarter
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.63	USD	1 Quarter
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.88	USD	1 Quarter
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.88	USD	1 Quarter
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.63	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.46M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	7.49M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.49M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.46M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$320.75K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$97.41K	USD	1 Quarter
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of convertible notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-1.77M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$571.50K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$1.70M	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$10.00K	USD	1 Quarter
Provision for bad debts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$840.03K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.06M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-69.30K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$46.10K	USD	1 Quarter
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$24.27K	USD	1 Quarter
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$121.85K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-638.07K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-169.99K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-146.21K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$176.54K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.70M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.16M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$104.69K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$329.54K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-104.69K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-329.54K	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.61M	USD	1 Quarter
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.67M	USD	1 Quarter
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$939.95K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.55M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.81M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.75M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.75M	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest paid in kind	`PaidInKindInterest`	-	USD	1 Quarter
Interest paid in kind	`PaidInKindInterest`	$35.62K	USD	1 Quarter
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	-	USD	1 Quarter
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$641.98K	USD	1 Quarter
Issuance of stock options for payment of accrued bonus	`IssuanceOfStockOptionsIssuedForPaymentOfAccruedBonus`	-	USD	1 Quarter
Issuance of stock options for payment of accrued bonus	`IssuanceOfStockOptionsIssuedForPaymentOfAccruedBonus`	$300.00K	USD	1 Quarter
FV of warrants issued	`FairValueOfWarrantsIssued`	-	USD	1 Quarter
FV of warrants issued	`FairValueOfWarrantsIssued`	$1.07M	USD	1 Quarter

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$2.61M	USD	1 Quarter
Fair value of warrants issued in connection with convertible note repayment	`WarrantsIssuedDuringPeriodValueWarrants`	$1.64M	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$571.50K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.70M	USD	1 Quarter
Options issued in settlement of accrued bonus	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$300.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.81M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.72M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.71M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	7.49M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.